DOP2012000277A - Comprimido de desintegracion por via oral que contiene acarbosa - Google Patents
Comprimido de desintegracion por via oral que contiene acarbosaInfo
- Publication number
- DOP2012000277A DOP2012000277A DO2012000277A DO2012000277A DOP2012000277A DO P2012000277 A DOP2012000277 A DO P2012000277A DO 2012000277 A DO2012000277 A DO 2012000277A DO 2012000277 A DO2012000277 A DO 2012000277A DO P2012000277 A DOP2012000277 A DO P2012000277A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- deintegration
- compressed
- acarbose
- via containing
- containing acarbose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Era un objeto de la presente invención proporcionar un comprimido de desintegración por vía oral (ODT) para el inhibidor de la glucosidasa acarbosa. El objetivo se consigue con un comprimido de desintegración por vía oral que contiene un 1-30 % de acarbosa y un 40-90 % de vehículo soluble en agua. Con el fin de obtener las propiedades deseadas, se tienen que compactar previamente los ingredientes y mezclar previamente con un vehículo insoiuble.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10161114 | 2010-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2012000277A true DOP2012000277A (es) | 2012-12-15 |
Family
ID=44344015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2012000277A DOP2012000277A (es) | 2010-04-27 | 2012-10-26 | Comprimido de desintegracion por via oral que contiene acarbosa |
Country Status (26)
Country | Link |
---|---|
US (1) | US20130131003A1 (es) |
EP (1) | EP2563329B1 (es) |
JP (1) | JP5944378B2 (es) |
KR (1) | KR101788350B1 (es) |
CN (2) | CN102905687A (es) |
AU (1) | AU2011247642C1 (es) |
BR (1) | BR112012027303A2 (es) |
CA (1) | CA2797365A1 (es) |
CL (1) | CL2012003011A1 (es) |
CO (1) | CO6640213A2 (es) |
CR (1) | CR20120548A (es) |
CU (1) | CU20120152A7 (es) |
DO (1) | DOP2012000277A (es) |
EC (1) | ECSP12012279A (es) |
ES (1) | ES2623025T3 (es) |
GT (1) | GT201200290A (es) |
IL (1) | IL222368B (es) |
MX (1) | MX348865B (es) |
MY (1) | MY179724A (es) |
NZ (1) | NZ603199A (es) |
PE (1) | PE20130403A1 (es) |
SG (2) | SG184851A1 (es) |
SI (1) | SI2563329T1 (es) |
TW (1) | TWI556823B (es) |
UA (1) | UA111155C2 (es) |
WO (1) | WO2011134962A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201100150A2 (tr) * | 2011-01-06 | 2012-07-23 | Bi̇lgi̇ç Mahmut | Suda çözünür dozaj formları |
WO2013115741A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Pharmaceutical compositions comprising alpha-glucosidase inhibitor |
WO2013115738A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Micronized acarbose |
CA2922849A1 (en) | 2012-08-31 | 2014-03-06 | Ixchel Pharma, Llc | Agents useful for treating obesity, diabetes and related disorders |
CN104013590A (zh) * | 2014-05-09 | 2014-09-03 | 万特制药(海南)有限公司 | 一种含阿卡波糖的药物组合物及其制备方法 |
EP3233066B1 (en) | 2014-12-17 | 2021-11-10 | Empros Pharma AB | A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders |
CN105213341A (zh) * | 2015-10-29 | 2016-01-06 | 无锡福祈制药有限公司 | 一种阿卡波糖片及其制备方法 |
CN113081984B (zh) * | 2021-04-19 | 2023-06-02 | 北京阳光诺和药物研究股份有限公司 | 一种阿卡波糖口崩片及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3134591A1 (de) * | 1981-09-01 | 1983-03-10 | Bayer Ag, 5090 Leverkusen | Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren |
JPH10182687A (ja) * | 1996-10-21 | 1998-07-07 | Bayer Yakuhin Kk | アカルボースの貯蔵安定化法 |
DE19802700A1 (de) * | 1998-01-24 | 1999-07-29 | Bayer Ag | Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält |
US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
KR100682836B1 (ko) * | 2004-12-06 | 2007-02-15 | 엘지전자 주식회사 | 유기 전계 발광 소자 |
US20060229261A1 (en) * | 2005-04-12 | 2006-10-12 | John Devane | Acarbose methods and formulations for treating chronic constipation |
MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
WO2007099908A1 (ja) * | 2006-02-27 | 2007-09-07 | Matsushita Electric Industrial Co., Ltd. | ウェアラブル端末、および、携帯撮像収音装置、およびそれらを実現する装置、方法、プログラム |
FI20070521L (fi) * | 2006-11-10 | 2008-05-11 | Atacama Labs Oy | Rakeita, tabletteja ja rakeistusmenetelmä |
CN101411715B (zh) * | 2007-10-19 | 2012-03-28 | 杭州华东医药集团生物工程研究所有限公司 | 含有阿卡波糖的药物组合物 |
JP5291324B2 (ja) * | 2007-11-01 | 2013-09-18 | 沢井製薬株式会社 | 口腔内崩壊錠 |
JP2009114113A (ja) * | 2007-11-06 | 2009-05-28 | Nipro Corp | 口腔内崩壊錠及びその製造方法 |
RU2010128019A (ru) * | 2007-12-08 | 2012-01-20 | Байер Шеринг Фарма Акциенгезельшафт (DE) | Пероральная диспергируемая таблетка |
AR069875A1 (es) * | 2007-12-21 | 2010-02-24 | Eurand Inc | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion |
CN102088959B (zh) * | 2008-06-20 | 2016-05-25 | 默克专利股份有限公司 | 可直接压缩的且快速崩解的片剂基质 |
-
2011
- 2011-04-26 SG SG2012076147A patent/SG184851A1/en unknown
- 2011-04-26 UA UAA201213526A patent/UA111155C2/uk unknown
- 2011-04-26 US US13/643,929 patent/US20130131003A1/en not_active Abandoned
- 2011-04-26 ES ES11716264.4T patent/ES2623025T3/es active Active
- 2011-04-26 SG SG10201505844WA patent/SG10201505844WA/en unknown
- 2011-04-26 MY MYPI2012700818A patent/MY179724A/en unknown
- 2011-04-26 KR KR1020127028046A patent/KR101788350B1/ko active IP Right Grant
- 2011-04-26 CN CN2011800205487A patent/CN102905687A/zh active Pending
- 2011-04-26 EP EP11716264.4A patent/EP2563329B1/en active Active
- 2011-04-26 JP JP2013506633A patent/JP5944378B2/ja active Active
- 2011-04-26 NZ NZ603199A patent/NZ603199A/en not_active IP Right Cessation
- 2011-04-26 PE PE2012002079A patent/PE20130403A1/es not_active Application Discontinuation
- 2011-04-26 CN CN201610934162.1A patent/CN106924199A/zh active Pending
- 2011-04-26 BR BR112012027303A patent/BR112012027303A2/pt not_active IP Right Cessation
- 2011-04-26 AU AU2011247642A patent/AU2011247642C1/en not_active Ceased
- 2011-04-26 CA CA2797365A patent/CA2797365A1/en not_active Abandoned
- 2011-04-26 SI SI201131170A patent/SI2563329T1/sl unknown
- 2011-04-26 WO PCT/EP2011/056587 patent/WO2011134962A2/en active Application Filing
- 2011-04-26 MX MX2012012459A patent/MX348865B/es active IP Right Grant
- 2011-04-26 TW TW100114368A patent/TWI556823B/zh not_active IP Right Cessation
-
2012
- 2012-10-11 IL IL222368A patent/IL222368B/en active IP Right Grant
- 2012-10-25 CU CU2012000152A patent/CU20120152A7/es unknown
- 2012-10-26 GT GT201200290A patent/GT201200290A/es unknown
- 2012-10-26 EC ECSP12012279 patent/ECSP12012279A/es unknown
- 2012-10-26 CR CR20120548A patent/CR20120548A/es unknown
- 2012-10-26 CL CL2012003011A patent/CL2012003011A1/es unknown
- 2012-10-26 DO DO2012000277A patent/DOP2012000277A/es unknown
- 2012-10-26 CO CO12192234A patent/CO6640213A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2012000277A (es) | Comprimido de desintegracion por via oral que contiene acarbosa | |
CO6410279A2 (es) | Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente. | |
AR077199A1 (es) | Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia | |
CL2016001547A1 (es) | Composiciones para el cuidado oral | |
ECSP13012844A (es) | Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales | |
GT201400196A (es) | Compuestos de heterociclilo | |
ECSP13012715A (es) | Método para producir preparados farmacéuticos con contenido de ibp | |
GT201300266A (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
GT201200165A (es) | Triazolopiridinas | |
GT201300137A (es) | Derivados de imidazo [1,2-b] piridazina e imidazo [4,5-b] piridina como inhibidores de jak | |
DOP2015000170A (es) | Compuestos químicos | |
AR081670A1 (es) | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo | |
BR112015008912A2 (pt) | composições solidificáveis compreendendo volastonita e pedra-pomes e métodos de uso | |
MX2013001234A (es) | Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a. | |
UY34800A (es) | Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos | |
CL2013003093A1 (es) | Composiciones que comprende cation de polihidroxioxoaluminio detectable por rmn; metodo de fabricacion de los mismos; y su uso. | |
HN2009001330A (es) | Compuestos novedosos activos como antagonistas de receptore muscarinico | |
BRPI1007291A2 (pt) | método de uso de um líquido iônico para armazenar hidrogênio | |
AR089114A1 (es) | PREVENCION DE LOS EFECTOS ADVERSOS CAUSADOS POR LOS ANTICUERPOS BIESPECIFICOS EpCAMxCD3 | |
MY171526A (en) | Pharmaceutical formulation for reducing frequency of urination and method of use thereof | |
CL2013000335A1 (es) | Forma altamente cristalina de valsartan; proceso para prepararla; composicion farmaceutica que la comprende y uso en el tratamiento de la hipertension. | |
BR112013010491A2 (pt) | pó de poliol e polissacarídeo comprimível e altamente viscoso | |
NI201300100A (es) | Derivados de tieno [2, 3-d] pirimidina y su uso para tratar arritmias | |
AR090830A1 (es) | Cocristales de metalaxil y protioconazol y procedimientos para la fabricacion y el uso de los mismos | |
BRPI1015136A2 (pt) | composições de vacina para esquistossomose e métodos de uso |